መነሻ › አሠሪዎች › Regeneron Pharmaceuticals, Inc. › Principal IT Applications Analyst
Principal IT Applications Analyst በRegeneron Pharmaceuticals, Inc.፡ የH-1B ደመወዞች
5 የሥራ ሁኔታ ማመልከቻዎች ለRegeneron Pharmaceuticals, Inc. በPrincipal IT Applications Analyst የሥራ መደብ። መካከለኛ የቀረበ መሠረታዊ ደመወዝ $134,040፤ መካከለኛ ግማሽ $125,104–$140,000።
ማመልከቻዎች (LCAs)5
መካከለኛ የሚቀርብ ደመወዝ$134,040
የደመወዞች መካከለኛ ግማሽ$125,104–$140,000
ከ10ኛ እስከ 90ኛ ፐርሰንታይል$122,042–$144,291
በፊስካል ዓመት
| የፋይናንስ ዓመት | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| FY2024 | 1 | $147,151 |
| FY2025 | 2 | $137,020 |
| FY2026 | 2 | $122,552 |
ማመልከቻዎች
| መሠረታዊ ደመወዝ | አድራሻ | የቀረበበት | የመጀመሪያ ቀን | ሁኔታ |
|---|---|---|---|---|
| $120,000–$150,000 ደረጃ IV | Troy, NY | 5 ጃንዩ 2026 | 2 ፌብሩ 2026 | የተረጋገጠ |
| $125,104 ደረጃ IV | Troy, NY | 12 ኖቬም 2025 | 31 ማርች 2026 | የተረጋገጠ |
| $134,040 ደረጃ II | Troy, NY | 7 ጃንዩ 2025 | 6 ጁን 2025 | የተረጋገጠ |
| $140,000 ደረጃ III | Troy, NY | 16 ዲሴም 2024 | 6 ጃንዩ 2025 | የተረጋገጠ |
| $147,151 ደረጃ III | Troy, NY | 31 ጁላይ 2024 | 7 ጃንዩ 2025 | የተረጋገጠ |
ሌሎች ሥራዎች በRegeneron Pharmaceuticals, Inc.
- Senior Scientist$138,728
- Principal Scientist$159,918
- Associate Scientist$88,900
- Sr. Scientist$142,799
- Scientist$116,358
- Principal Biostatistician$149,537
- Postdoctoral Fellow$95,997
- Principal Statistical Programmer$150,000
- Senior Associate Scientist$100,267
- Staff Engineer$157,948
- Sr Associate Scientist$100,540
- Manager, Data Management$160,000
- Sr Assoc Scientist$98,619
- Sr Mgr Statistical Programming$189,046
- Sr. Statistical Programmer$126,460
- Mgr Statistical Programming$163,640
- Mgr Biostatistics$163,620
- Process Development Engineer III$137,918
- Manager, Statistical Programming$163,250
- Senior Data Manager$145,000
- Statistical Programmer$104,522
- Senior Manager, Biostatistics$187,620
- Manager, Biostatistics$167,896
- Associate Director$200,000
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።